Yıl: 2022 Cilt: 14 Sayı: 2 Sayfa Aralığı: 74 - 80 Metin Dili: İngilizce DOI: 10.4274/raed.galenos.2022.47966 İndeks Tarihi: 19-09-2022

Comparison of cranial and extra-cranial involvement of patients with giant cell arteritis

Öz:
Objective: Giant cell arteritis (GCA) is a chronic granulomatous inflammation of medium and large sized arteries; it is also known as temporal arteritis. The aim of the study was to investigate the clinical, laboratory and radiological findings of the patients diagnosed with GCA and to compare cranial, extra-cranial (ECI) and either involvement patterns. Methods: The study was designed as cross-sectional. The demographic and clinical data, laboratory results, imaging and biopsy findings were documented. The patients were divided into three groups according to the involved regions. Results: Twenty-four patients with GCA were evaluated. When patients were divided into three groups as cranial (CI), ECI and both cranial and extra-cranial (CECI) involvement; vision loss, jaw claudication, scalp tenderness, temporal artery stiffness, tenderness and pulselessness were common in patients with CI. Weight loss was significantly higher in patients with ECI than in patients with CI. Positron emission tomography (PET) was performed in 50% of GCA patients; vasculitic involvement was found in all of the 5 patients with ECI and CECI, whereas it was not observed in 7 patients with CI. Conclusion: GCA is a vasculitis that is among the large vessel vasculitides, but until recently, its CI findings were better defined than its systemic involvement. With the widespread use of modern imaging techniques, ECI involvement accompanying CI involvement and isolated ECI involvement has been better defined. Constitutional symptoms and positive PET findings were more prominent in patients with ECI, which is thought to be related to systemic disease pattern.
Anahtar Kelime:

Dev hücreli arteritte kraniyal ve ekstra-kraniyal tutulumların karşılaştırılması

Öz:
Amaç: Dev hücreli arterit (DHA), orta ve büyük çaplı arterlerin kronik granülomatöz enflamasyonudur; temporal arterit olarak da bilinir. Çalışmanın amacı DHA tanısı konulan hastaların klinik, laboratuvar ve radyolojik bulgularının araştırılması ve kraniyal (CI), ekstra-kraniyal (ECI) ve her iki bölgede tutulum paternlerinin karşılaştırılmasıdır. Yöntem: Çalışma kesitsel olarak tasarlanmıştır. Demografik ve klinik veriler, laboratuvar sonuçları, görüntüleme ve biyopsi bulguları kaydedilerek, hastalar tutulum bölgelerine göre üç gruba ayrılmıştır. Bulgular: DHA’lı yirmi dört hasta değerlendirildi. Hastalar CI, ECI ve kraniyal ve ekstrakraniyal (CECI) tutulum olarak üç gruba ayrıldığında; görme kaybı, çene kladikasyosu, saçlı deride hassasiyet, temporal arterde sertlik, hassasiyet ve nabızsızlık CI grubunda daha yaygındı. Kilo kaybı ECI’lı hastalarda CI’lı hastalara göre anlamlı olarak daha yüksekti. Pozitron emisyon tomografisi (PET), DHA hastalarının %50’sine çekilmişti; ECI ve CECI’lı 5 hastanın tümünde vaskülitik tutulum bulunurken, CI’lı yedi hastada tutulum gözlenmedi. Sonuç: DHA, büyük damar vaskülitleri arasında yer alan bir vaskülittir ancak yakın zamana kadar kraniyal bulguları sistemik tutulumdan daha iyi tanımlanmıştır. Modern görüntüleme tekniklerinin yaygınlaşması ile kraniyal tutulumlara eşlik eden ECI tutulumlar ve izole ECI tutulumlar daha iyi tanımlanmıştır. Konstitüsyonel semptomlar ve pozitif PET bulguları ECI olan hastalarda daha belirgin olup, bu daha sistemik bir hastalık paterni ile ilişkili olarak değerlendirilmiştir.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Buttgereit F, Dejaco C, Matteson El, Dasgupta B. Polymyalgia Rheumatica And Giant Cell Arteritis: A Systematic Review. JAMA 2016;315:2442-58.
  • 2. Gonzalez-Gay MA, Vazquez-Rodriguez TR, Lopez-Diaz MJ, et al. Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum 2009;61:1454-61.
  • 3. Meller J, Sahlmann CO, Gurocak O, Liersch T, Meller B. FDGPET in patients with fever of unknown origin: the importance of diagnosing large vessel vasculitis. Q J Nucl Med Mol Imaging 2009;53:51-63.
  • 4. Gonzalez-Gay MA, Barros S, Lopez-Diaz MJ, Garcia-Porrua C, Sanchez-Andrade A, Llorca J. Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients. Medicine (Baltimore) 2005;84:269-76.
  • 5. Ninan J, Lester S, Hill C. Giant Cell Arteritis. Best Pract Res Clin Rheumatol 2016;30:169-88.
  • 6. Pelletier-Galarneau M, Ruddy TD. PET/CT for Diagnosis and Management of Large-Vessel Vasculitis. Curr Cardiol Rep 2019;21:34.
  • 7. Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33:1122-8.
  • 8. Schmidt WA, Seifert A, Gromnica-Ihle E, Krause A, Natusch A. Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis. Rheumatology (Oxford) 2008;47:96-101.
  • 9. Muratore F, Kermani TA, Crowson CS, et al. Large-vessel giant cell arteritis: a cohort study. Rheumatology (Oxford) 2015;54:463-70.
  • 10. Kermani TA, Schmidt J, Crowson CS, et al. Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis. Semin Arthritis Rheum 2012;41:866-71.
  • 11. Parikh M, Miller NR, Lee AG, et al. Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis. Ophthalmology 2006;113:1842-5.
  • 12. Czihal M, Zanker S, Rademacher A, et al. Sonographic and clinical pattern of extracranial and cranial giant cell arteritis. Scand J Rheumatol 2012;41:231-6.
  • 13. Ghinoi A, Pipitone N, Nicolini A, et al. Large-vessel involvement in recent-onset giant cell arteritis: a case-control colour – Doppler sonography study. Rheumatology (Oxford) 2012;51:730-4.
  • 14. Van der Geest KSM, Treglia G, Glaudemans AWJM, et al. Diagnostic value of [18F] FDG-PET/CT in polymyalgia rheumatica: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging 2021;48:1876-89.
  • 15. Dejaco C, Ramiro S, Duftner C, et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis 2018;77:636-43.
  • 16. De Boysson H, Lambert M, Liozon E, et al. Giant-cell arteritis without cranial manifestations: Working diagnosis of a distinct disease pattern. Medicine (Baltimore) 2016;95:e3818.
  • 17. Blockmans D, Bley T, Schmidt W. Imaging for large-vessel vasculitis. Curr Opin Rheumatol 2009;21:19-28.
  • 18. Lie JT. Illustrated histopathologic classification criteria for selected vasculitis syndromes. American College of Rheumatology Subcommittee on Classification of Vasculitis. Arthritis Rheum 1990;33:1074-87.
  • 19. Brack A, Martinez-Taboada V, Stanson A, Goronzy JJ, Weyand CM. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum 1999;42:311-7.
  • 20. Bajocchi G, Zamorani G, Cavazza A, et al. Giant-cell arteritis of the female genital tract associated with occult temporal arteritis and FDG-PET evidence of large-vessel vasculitis. Clin Exp Rheumatol 2007;25(1 Suppl 44):S36-9.
APA Komac A, Özdemir Işık Ö, Yazici A, Cefle A (2022). Comparison of cranial and extra-cranial involvement of patients with giant cell arteritis. , 74 - 80. 10.4274/raed.galenos.2022.47966
Chicago Komac Andac,Özdemir Işık Özlem,Yazici Ayten,Cefle Ayse Comparison of cranial and extra-cranial involvement of patients with giant cell arteritis. (2022): 74 - 80. 10.4274/raed.galenos.2022.47966
MLA Komac Andac,Özdemir Işık Özlem,Yazici Ayten,Cefle Ayse Comparison of cranial and extra-cranial involvement of patients with giant cell arteritis. , 2022, ss.74 - 80. 10.4274/raed.galenos.2022.47966
AMA Komac A,Özdemir Işık Ö,Yazici A,Cefle A Comparison of cranial and extra-cranial involvement of patients with giant cell arteritis. . 2022; 74 - 80. 10.4274/raed.galenos.2022.47966
Vancouver Komac A,Özdemir Işık Ö,Yazici A,Cefle A Comparison of cranial and extra-cranial involvement of patients with giant cell arteritis. . 2022; 74 - 80. 10.4274/raed.galenos.2022.47966
IEEE Komac A,Özdemir Işık Ö,Yazici A,Cefle A "Comparison of cranial and extra-cranial involvement of patients with giant cell arteritis." , ss.74 - 80, 2022. 10.4274/raed.galenos.2022.47966
ISNAD Komac, Andac vd. "Comparison of cranial and extra-cranial involvement of patients with giant cell arteritis". (2022), 74-80. https://doi.org/10.4274/raed.galenos.2022.47966
APA Komac A, Özdemir Işık Ö, Yazici A, Cefle A (2022). Comparison of cranial and extra-cranial involvement of patients with giant cell arteritis. Ulusal Romatoloji Dergisi, 14(2), 74 - 80. 10.4274/raed.galenos.2022.47966
Chicago Komac Andac,Özdemir Işık Özlem,Yazici Ayten,Cefle Ayse Comparison of cranial and extra-cranial involvement of patients with giant cell arteritis. Ulusal Romatoloji Dergisi 14, no.2 (2022): 74 - 80. 10.4274/raed.galenos.2022.47966
MLA Komac Andac,Özdemir Işık Özlem,Yazici Ayten,Cefle Ayse Comparison of cranial and extra-cranial involvement of patients with giant cell arteritis. Ulusal Romatoloji Dergisi, vol.14, no.2, 2022, ss.74 - 80. 10.4274/raed.galenos.2022.47966
AMA Komac A,Özdemir Işık Ö,Yazici A,Cefle A Comparison of cranial and extra-cranial involvement of patients with giant cell arteritis. Ulusal Romatoloji Dergisi. 2022; 14(2): 74 - 80. 10.4274/raed.galenos.2022.47966
Vancouver Komac A,Özdemir Işık Ö,Yazici A,Cefle A Comparison of cranial and extra-cranial involvement of patients with giant cell arteritis. Ulusal Romatoloji Dergisi. 2022; 14(2): 74 - 80. 10.4274/raed.galenos.2022.47966
IEEE Komac A,Özdemir Işık Ö,Yazici A,Cefle A "Comparison of cranial and extra-cranial involvement of patients with giant cell arteritis." Ulusal Romatoloji Dergisi, 14, ss.74 - 80, 2022. 10.4274/raed.galenos.2022.47966
ISNAD Komac, Andac vd. "Comparison of cranial and extra-cranial involvement of patients with giant cell arteritis". Ulusal Romatoloji Dergisi 14/2 (2022), 74-80. https://doi.org/10.4274/raed.galenos.2022.47966